News
14m
The Cool Down on MSNScientists achieve breakthrough solution to decades-long issue with virtually limitless energy device: 'Charting a path'"Addresses the commercially critical metrics of cost, efficiency, and reliability." Scientists achieve breakthrough solution ...
Advancing a broad, potential best-in-class orexin receptor 2 (OX2R) agonist franchise, with key data readouts expected this year ORX750 Phase 2a CRYSTAL-1 study for the treatment of narcolepsy type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results